Biotin anti-mouse CD45 [30-F11] and 5 more items

BioLegend Inc. was awarded contract A207_PO-0460191 by the University of Virginia on July 27, 2026, with a cumulative value of $1,297.00. The contract covers the delivery of specialized immunological research reagents and biological compounds to Min Xiang at the University of Virginia in Virginia. The procured items include monoclonal antibodies conjugated to fluorescent markers for flow cytometry applications, specifically targeting mouse immune cell surface antigens including CD45 (pan-leukocyte marker), FR4 (Folate Receptor 4), CD357 (GITR), CD185 (CXCR5), and CD279 (PD-1), along with Brefeldin A Solution for protein transport inhibition in cell culture applications.

The contract comprises six line items delivered in varying quantities, with individual unit prices ranging from $45.50 to $308.00. The reagents are conjugated to multiple fluorescent detection platforms including Biotin, PE/Cyanine7, PerCP/Cyanine5.5, and Brilliant Violet 711 technologies, which are standard tools for multiparameter flow cytometric analysis in immunological research. These research-grade biologics are typically used for characterization and analysis of mouse immune cell populations in laboratory and translational research settings conducted within the University of Virginia's research infrastructure.